Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle
Reneo Pharmaceuticals Inc. Common Stock | FinOracle

Reneo Pharmaceuticals Inc. Common Stock

Symbol: (NASDAQ:RPHM)

Reneo Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing innovative therapies for patients suffering from rare genetic diseases. Their research focuses on identifying and targeting specific molecular pathways to address the underlying cause of these diseases. With a dedicated team of researchers and a strong pipeline of potential treatments, Reneo Pharmaceuticals is poised to make a significant impact in the field of rare disease therapeutics.

Latest News

No Content Available

Welcome Back!

Login to your account below

Create New Account!

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.

Home
Trends
Premium
Favorite
Account
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?